Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

OBJECTIVE: Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) can present with a broad spectrum of signs and symptoms. The relative effects of different manifestations on health-related quality of life (HRQOL) are unknown. METHODS: We conducted an individual patient data meta-analysis o...

Full description

Bibliographic Details
Main Authors: Walsh, M, Mukhtyar, C, Mahr, A, Herlyn, K, Luqmani, R, Merkel, P, Jayne, DR
Format: Journal article
Language:English
Published: 2011
_version_ 1797071714509651968
author Walsh, M
Mukhtyar, C
Mahr, A
Herlyn, K
Luqmani, R
Merkel, P
Jayne, DR
author_facet Walsh, M
Mukhtyar, C
Mahr, A
Herlyn, K
Luqmani, R
Merkel, P
Jayne, DR
author_sort Walsh, M
collection OXFORD
description OBJECTIVE: Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) can present with a broad spectrum of signs and symptoms. The relative effects of different manifestations on health-related quality of life (HRQOL) are unknown. METHODS: We conducted an individual patient data meta-analysis of baseline Short Form 36 (SF-36) scores from 4 randomized controlled trials of patients with newly diagnosed AAV. We determined the associations between organ manifestations at trial entry and the SF-36 physical composite score (PCS) and mental composite score (MCS) using mixed-effects models adjusted for demographic factors. Associations with each of the 8 domains of the SF-36 were further explored using multivariate multiple regression. RESULTS: SF-36 data were available from 346 patients. Older age (-0.11 points/year [95% confidence interval (95% CI) -0.21, -0.012]; P = 0.029) and neurologic involvement (-5.84 points; P < 0.001) at baseline were associated with lower PCS. Physical functioning scores were the most affected and older age scores (-0.25 points/year [95% CI -0.38, -0.11]; P < 0.001) and neurologic involvement (-8.48 points [95% CI -12.90, -4.06]; P < 0.001) had the largest effects. The MCS was negatively affected only by chest involvement (P = 0.027), but this effect was not exerted in any particular domain. CONCLUSION: In patients with newly diagnosed AAV, HRQOL is complex and incompletely explained by their organ system manifestations.
first_indexed 2024-03-06T22:57:19Z
format Journal article
id oxford-uuid:60e09632-d4d8-4ffd-b458-01db4285ffdd
institution University of Oxford
language English
last_indexed 2024-03-06T22:57:19Z
publishDate 2011
record_format dspace
spelling oxford-uuid:60e09632-d4d8-4ffd-b458-01db4285ffdd2022-03-26T17:55:57ZHealth-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:60e09632-d4d8-4ffd-b458-01db4285ffddEnglishSymplectic Elements at Oxford2011Walsh, MMukhtyar, CMahr, AHerlyn, KLuqmani, RMerkel, PJayne, DROBJECTIVE: Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) can present with a broad spectrum of signs and symptoms. The relative effects of different manifestations on health-related quality of life (HRQOL) are unknown. METHODS: We conducted an individual patient data meta-analysis of baseline Short Form 36 (SF-36) scores from 4 randomized controlled trials of patients with newly diagnosed AAV. We determined the associations between organ manifestations at trial entry and the SF-36 physical composite score (PCS) and mental composite score (MCS) using mixed-effects models adjusted for demographic factors. Associations with each of the 8 domains of the SF-36 were further explored using multivariate multiple regression. RESULTS: SF-36 data were available from 346 patients. Older age (-0.11 points/year [95% confidence interval (95% CI) -0.21, -0.012]; P = 0.029) and neurologic involvement (-5.84 points; P < 0.001) at baseline were associated with lower PCS. Physical functioning scores were the most affected and older age scores (-0.25 points/year [95% CI -0.38, -0.11]; P < 0.001) and neurologic involvement (-8.48 points [95% CI -12.90, -4.06]; P < 0.001) had the largest effects. The MCS was negatively affected only by chest involvement (P = 0.027), but this effect was not exerted in any particular domain. CONCLUSION: In patients with newly diagnosed AAV, HRQOL is complex and incompletely explained by their organ system manifestations.
spellingShingle Walsh, M
Mukhtyar, C
Mahr, A
Herlyn, K
Luqmani, R
Merkel, P
Jayne, DR
Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
title Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
title_full Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
title_fullStr Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
title_full_unstemmed Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
title_short Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
title_sort health related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody associated vasculitis
work_keys_str_mv AT walshm healthrelatedqualityoflifeinpatientswithnewlydiagnosedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT mukhtyarc healthrelatedqualityoflifeinpatientswithnewlydiagnosedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT mahra healthrelatedqualityoflifeinpatientswithnewlydiagnosedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT herlynk healthrelatedqualityoflifeinpatientswithnewlydiagnosedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT luqmanir healthrelatedqualityoflifeinpatientswithnewlydiagnosedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT merkelp healthrelatedqualityoflifeinpatientswithnewlydiagnosedantineutrophilcytoplasmicantibodyassociatedvasculitis
AT jaynedr healthrelatedqualityoflifeinpatientswithnewlydiagnosedantineutrophilcytoplasmicantibodyassociatedvasculitis